Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Price

Showing results (1201-1210 of 1,974) with videos related to

Pageof 198
Sort By:
Lancet (London, England)|August 31, 1996
Risk factors for ifosfamide nephrotoxicity in childrenR Skinner, A D Pearson, M W English, et al.
Experimental Neurology|December 1, 1990
Trophic actions of recombinant human nerve growth factor on cultured rat embryonic CNS cellsB Knüsel, L E Burton, F M Longo, et al.
Archives of Neurology|March 20, 2001
Mild cognitive impairment represents early-stage Alzheimer diseaseJ C Morris, M Storandt, J P Miller, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|February 14, 2017
Magnetic critical scattering in solid Co<sub>80</sub>Pd<sub>20</sub>H E Fischer, L Hennet, V Cristiglio, et al.
Biochemistry|May 24, 2008
A hydrogen bond in loop A is critical for the binding and function of the 5-HT3 receptorKerry L Price, Kiowa S Bower, Andrew J Thompson, et al.
The Journal of Physical Chemistry Letters|January 21, 2017
Relaxation in a Prototype Ionic Liquid: Influence of Water on the DynamicsDavid L Price, Oleg Borodin, Miguel A González, et al.
The Journal of Clinical Investigation|April 5, 2000
Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1M A Sussman, S Welch, A Walker, et al.
The Journal of Biological Chemistry|March 23, 2005
Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand bindingAndrew J Thompson, Kerry L Price, David C Reeves, et al.
European Journal of Pharmacology|December 18, 2007
5-Fluorotryptamine is a partial agonist at 5-HT3 receptors, and reveals that size and electronegativity at the 5 position of tryptamine are critical for efficient receptor functionKiowa S Bower, Kerry L Price, Laura E C Sturdee, et al.
Physiological Genomics|September 21, 2006
Microarray interrogation of human metanephric mesenchymal cells highlights potentially important molecules in vivoKaren L Price, David A Long, Nipurna Jina, et al.
Pageof 198

Showing results (1201-1210 of 1,974) with videos related to

Sort By:
Pageof 198
Lancet (London, England)|August 31, 1996
Risk factors for ifosfamide nephrotoxicity in childrenR Skinner, A D Pearson, M W English, et al.
Experimental Neurology|December 1, 1990
Trophic actions of recombinant human nerve growth factor on cultured rat embryonic CNS cellsB Knüsel, L E Burton, F M Longo, et al.
Archives of Neurology|March 20, 2001
Mild cognitive impairment represents early-stage Alzheimer diseaseJ C Morris, M Storandt, J P Miller, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|February 14, 2017
Magnetic critical scattering in solid Co<sub>80</sub>Pd<sub>20</sub>H E Fischer, L Hennet, V Cristiglio, et al.
Biochemistry|May 24, 2008
A hydrogen bond in loop A is critical for the binding and function of the 5-HT3 receptorKerry L Price, Kiowa S Bower, Andrew J Thompson, et al.
The Journal of Physical Chemistry Letters|January 21, 2017
Relaxation in a Prototype Ionic Liquid: Influence of Water on the DynamicsDavid L Price, Oleg Borodin, Miguel A González, et al.
The Journal of Clinical Investigation|April 5, 2000
Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1M A Sussman, S Welch, A Walker, et al.
The Journal of Biological Chemistry|March 23, 2005
Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand bindingAndrew J Thompson, Kerry L Price, David C Reeves, et al.
European Journal of Pharmacology|December 18, 2007
5-Fluorotryptamine is a partial agonist at 5-HT3 receptors, and reveals that size and electronegativity at the 5 position of tryptamine are critical for efficient receptor functionKiowa S Bower, Kerry L Price, Laura E C Sturdee, et al.
Physiological Genomics|September 21, 2006
Microarray interrogation of human metanephric mesenchymal cells highlights potentially important molecules in vivoKaren L Price, David A Long, Nipurna Jina, et al.
Pageof 198